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Тумесцентната техника е техника на инфилтрација во супкутаното ткиво на голем волумен пуфериранфи-
зиолошки раствор во кој е потопена мала концентрација лидокаин заедно со адреналин. Овој раствор лесно 
и безболно се инфилтрира и доведува до анестезија на поткожното ткиво од одредени телесни регии како 
абдоменотили натколеното,обезбедува помало крвавење за време на интервенциите изведувани на кожата 
и поткожното ткиво. Тумесцентната локална анестезија (ТЛА) е многу лесна и сигурна процедура, која ши-
роко се употребува во многу хируршки гранки. Целта на трудот беше да се направи проценка на вредноста 
на тумесцентната локална анестезија кај липосукција. Материјал и методи: Беа евалуирани 16 пациентки со 
средна возраст од 32 години(24-46), кај кои  беше извршена липосукција на една до три регии, односно на 
вкупно 27 регии. Во тек на интервенцијата се употреби тумесцентната техника; инфилтрација на раствор од 
0,075% лидокаин со 1: 1.000.000 адреналин и 25 мл 8,4% бикарбонати во 1000 мл физиолошки раствор, средно 
инфилтриран раствор од 2506 мл (1600-5000), средна доза на лидокаин 25,9 мг/кг (18,9-50,6 мг/кг), вкупно 
средно инфилтриран лидокаин од 2010 мг (1360-4000мг). Резултати: ТЛА беше успешно реализирана; 68,8% 
(11) од пациентките беа среќни и задоволни, 12,5% (2) од пациентките имаа главоболка и вртоглавица, кај 12,5% 
(2) од пациентките беше сопрена интервенцијата поради силни болки, кај едната на една регија, кај другата 
на втората регија и кај 6,3% (1) од пациентките имаше лесни знаци за интоксикација со лидокаин. Немаше 
компликации кои бараа третман или хоспитализација, а немаше и смртен исход. Заклучок: Самостојно упо-
требена тумесцентна локална анестезија во доза од 18-50мг/кг лидокаин кај правилно избрани пациенти е 
сигурна техника за регионална анестезија за процедури на поткожното масно ткиво. 
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Tumescent technique is a technique of infiltration a large volume of buffered low concentration of lidocaine 
and adrenaline in normosaline in the subcutaneous tissue. This solution that is easily and painlessly infiltrated, 
anesthetizes a large area of subcutaneous tissue in particular body areas like: abdomen, thigh or arms; it 
provides less bleeding during procedures performed on the skin and subcutaneous tissue.  The tumescent 
local anesthesia (TLA) is a very simple and save procedure, widely used in many surgical branches. The aim of 
the paper was to assess the value of the tumescent local anesthesia during liposuction. Material and methods: 
Sixteen patients with a mean age of 32 years (24-46) underwent liposuction of one to three body areas, using 
tumescent technique, wide-awake. Тotal of 27 procedures were performed, with infiltration of solution of 
0.075% lidocaine with 1:1,000,000 adrenaline and 25 ml of 8.4% sodium bicarbonate in 1000 ml normosaline, 
mean infiltrated solution of 2506 ml (1600-5000), mean dosage of lidocaine 25.9 mg/kg (18.88-50.6 mg/kg), total 
amount of lidocaine 2010 mg (1360-4000 mg). Results: TLA was successfully realized; 68.8% (11) of patients were 
happy and satisfied, 12.5% (2) of patients had headache and dizziness, in 12.5% (2) of patients the procedure 
was stopped because of a severe pain, one in the first region and one in the second region, and in 6.3% (1) of 
patients mild signs of lidocaine toxicity were observed. There were no complications that needed treatment or 
hospitalization; also, there were no lethal cases. Conclusion: Sole tumescent local anesthesia at a dosage 18-50 
mg/kg lidocaine in prudent chosen patients seems to be safe regional anesthesia technique for the procedure 
of subcutaneous fat tissue.
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Introduction
Tumescent local anesthesia (TLA) is a tech-
nique of infiltration of a large volume of 
tumescent solution in the subcutaneous 
area, swells and firms (tumescence) that 
area, produces anesthesia of large areas of 
skin and subcutaneous tissue, also named 
as regional anesthesia, while the patient is 
awake and can cooperate with the surgeon 
(changing the position) during the proce-
dure, which is an important point for the 
esthetic procedures1.
Tumescent solution is an isotonic solution 
with lidocaine (0.05% or 0.1%), epineph-
rine (1:1,000,000) and sodium bicarbonate 
8.4%2.
TLA has been widely used and studied not 
only in plastic surgery, but also in general 
surgery, gynecology, vascular surgery, or-
thopedics3.
Current technique was popularized and re-
introduced in 1987 by Dr. Jeffrey A. Klein4, a 
dermatologist from USA; in fact, it is a vari-
ation of the much older technique known 
almost 110 years ago as “massive infiltra-
tion” or “hard infiltration.” This technique 
used as regional anesthesia has less blood 
loss during operation and less painful in-
filtration of high acid solution of diluted 
lidocaine in combination with adrenalin5. 
This technique has been shown to be sa-
feat high dose of lidocain and regarding 
lidocaine adsorption and toxicity6,7. 
The aim of the paper was to assess the 
value of tumescent anesthesia in patients 
who underwent liposuction.
Material and methods
Sixteen women underwent liposuction 
with tumescent local anesthesia (TLA) 
between September 2018 and Mart 2019. 
The mean age of the patients was 32 years 
(range 24-46). All patients underwent rou-
tine preoperative assessment, investiga-
tion for CBC (complete blood count) and 
bleeding profile-INR, aPTT (activated par-
tial thromboplastin time), platelets, BMI, 
menstrual cycle and breast ultrasound if 
needed. The examination also included 
use of all medications, vitamins, herbs, 
anticoagulants and contraceptive drugs as 
they may affect blood clotting. The usage 
of most of these drugs was to be discon-
tinued at least 2 weeks prior to surgery, so 
that they could not influence the bleeding 
time.
Preoperative marking session: After con-
sulting with the patient and having a clear 
idea of what she wanted to accomplish, ar-
eas were marked in a standing position, the 
areas wanted to be reduced were markedin 
a circular fashion (circle within a circle), 
where the inner circle (inside with crossed 
lines) represented the highest elevation 
and the outer circle the flattest; marking 
the muscles of both arms and buttocks. 
This is particularly important prior to li-
posuctionsince there is often variation in 
what body part the patient refers to and 
what the surgeon sees. Small incisions for 
liposuction cannula should be very dis-
crete, ideally hidden by the body’s natural 
folds and contours, while simultaneously 
allowing sufficient access to the targeted 
treatment area, and communicating with 
the patient. Since the liposuction is done 
with the patient in a lying position, these 
markings are very important for shaping 
the underlying areas. The most important 
issue about the marking session is to con-
firm - the treatment plan with the patient. 
There was no premedication.
The following formula and components for 
tumescent solution was used: 500 ml nor-
mal saline solution at room temperature, 
20 ml of 2% lidocaine (400 mg lidocaine), 
0.5 ml of epinephrine 1:1000 and 12.5 ml of 
8.4% sodium bicarbonate. The solution for 
lidocaine infiltration was preoperatively 
calculated by the patient weight - 20 mg/
kg lidocaine. Therefore, if the patient had 
70 kg, she was given about 1,400 mg lido-
caine, and if 1000 ml tumescent has 800 
mg, the calculated preoperative tumes-
cent solution was about 2,000 ml; however, 
sometimes during the procedure a larger 
dose was needed, and so the initial dosage 
for lidocaine was 20 mg/kg. The estimated 
tumescent solution was prepared prior to 
the intervention in a separate place, near 
the treatment room. 
Tumescent fluid infiltration and surgical 
procedure: Premedication or sedation 
during the intervention was not used. 
After establishing standard cleaning and 
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preparing the operating site, local infiltra-
tion was done using a blunt tipped lipo-
suction needle of 3 mm width, which was 
introduced through very small skin inci-
sions inserted with local anesthetic.The 
subcutaneous infiltration of a sufficiently 
large volume of solution produced a fine, 
tumescence and dimpled appearance of 
the skin texture that resembles the skin 
of an orange and blanching. It took 20-30 
min for infiltration for each area.Usually 
the suction of the fat was started 5-8 min-
utes after the end of infiltration to allow a 
proper anesthesia of the area and proper 
vasoconstriction of the subcutaneous tis-
sue, when the injected area is slightly firm 
and cool to the touch. Manual, power-as-
sisted suction with a large cannula 4-5 mm 
was done for removinga large amount of 
the fat, followed by using a thinner 3 mm 
cannula for smoother results. The cannu-
la is moved in a controlled back and forth 
fanning motion to dislodge fat. The excess 
fat is then sucked through the cannulae, 
vacuum system and collected in 3 liters 
medical containers, non-sterilized or ster-
ilized when fat is used for grafting.
Postoperative management: After clean-
ing and dressing of the incision sites,a 
high compression elastic post-liposuction 
garment was worn. Patients were able to 
leave the Clinic within 30 minutes to one 
hour after the completed procedure and 
were given advice for 24-hour rest, intake 
of 2-3 liters fluid and antibiotics for 5 days. 
The garment was worn 4 weeks. Two of 
the patients took low molecular heparin 
for 1 week.Monitoring of the patient is es-
sential for the sake of onset of pain, numb-
ness, dizziness, headache and blood pres-
sure, within one hour after the procedure. 
Patients are also asked about the personal 
satisfaction from the procedure. Contact 
with the patient during the 24 hours after 
the procedure is always made by telephone 
to detect any early signs of complications 
that may develop.
Results
The study comprised 16 healthy women 
with a mean age of 32 years (range 24-
46 years), mean body mass index (BMI) of 
29.06 (range 27-35); of them 62.5% (10 pa-
tients) were overweight and the rest were 
obese. In the period 2018 - 2019 these pa-
tients underwent liposuction procedure, 
involving treatment of 27 body areas. In 
Table 3 all treated body areas are shown: 
in 68.8% (11 patients) of the cases one area 
was treated, in 18.8% (3 patients) two ar-
eas, in 12.5% (2 patients) three areas, and 
in 31.3% (5 patients) fat grafting was per-
formed.
Localisation Number
 Double chin 1 (3.7%)
 Arms 8 (29.62%)
Abdomen - Upper and lower 8 (29.62%)
Upper  Abdomen 1 (3.7%)
Lower abdomen /
Abdomen  sides 1 (3.7%)
Love handles 1 (3.7%)
Back sides 1 (3.7%)
Hips 1 (3.7%)
Lower extremity /
Fat grafting Buttocks 2 (7.40%)
FG Breasts 1 (3.7%)
FG Hands 1 (3.7%)
 FG Hips 1 (3.7%)
Table  1.    Treated body areas
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Operating data: Table 2 gives data for 
each patient: the average amount of tu-
mescent solution infiltrated was 2506 
ml (range 1600-5000 ml) and the aver-
age lidocaine dosage was 25.96 mg/kg 
(range 18.88 mg/kg- 50.6 mg/kg) or total 
amount per patient 2010 mg (range 1360 
mg-4000 mg). The average aspirate vol-
ume was 1787 ml (range 1250-3500) and 
average amount of supernatant fat 1353 
ml (400-2700 ml). 
Tumescent 
solution in ml Aspirate in ml
Supernatant 
fat in ml
Total amount of 
lidocaine  in mg
Lidocaine
mg/kg
1. 2000 1750 1500 1600 mg  21.6
2. 2000 1300 700 1600 mg  21.3
3. 1700 1450 1050 1360 mg                      19.15
4. 2500 2300 1700 2000 mg                         23,80
5. 2700 2200 1600  2160 mg                        26.34
6. 3000 1600 1200  2400 mg                         26
7. 2500 2000 1400 2000 mg 26.6
8. 2000 1700 1300 1600 mg 20.25
9. 3500 1700 1500 2800 mg 38.3
10. 2000 2100 1800 1600 mg 23
11. 2000 1400 1200 1600 mg 22.5
12. 5000 3500 2700 4000 mg 50.6
13. 2500 1600 1450 2000 mg 28 
14. 1600 1500 1200 1360 mg 18.88
15. 1700ml+400mlfor grafting 1250 950 1680 mg 21.26
16.
2500 ml
+ 500 ml
for grafting
1250ml 400ml 2400 mg 27.9
mean 2 506 ml(1600-5000)
1787 ml
100%
(1250-3500)
1353 ml
(75.71%)
(400-2700)
Mean                     
2010 mg                 
(1360-4000 mg)
Mean
25.96 mg/kg
(18.88-50.6 mg/kg)
Table  2.    Data for each patient regarding infiltrated tumescent solution, aspirate, supernatant 
     fat, total amount of lidocaine and lidocaine in mg/kg.
Table 3 shows reactions of the patients 
during the intervention and reactions 
from tumescent solution:  68.8% (11 pa-
tients) were happy and satisfied, 12.5% 
(2 patients) had headache and dizziness, 
in 12.5% (2 patients) the procedure was 
stopped because of a severe pain, one 
in the first region and one in the second 
region, and in 6.3% (1 patient) of cases 
mild signs of lidocaine intoxication ap-
peared. There were no complications 
requiring treatment or hospitalization, 
and there were no lethal cases.
Table 4 presents the late complications 
that could occur and the incidence en-
countered after the procedure. In only 
6.3% (1 patient) of patients panniculitis 
in her upper arm developed, an inflam-
mation of subcutaneous adipose tissue, 
treated successfully in a few days with 
antibiotics and local anti-inflammatory 
ointments. There were no complica-
tions that needed hospitalization, and 
no deaths occurred.
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Number
Reaction upon intervention and signs of lidocaine intoxica-
tion 
Number of patients and percentages 8 (29.62%)
Happy 3  (18.75%)
Satisfied 8 (50%)
Headache 1  (6.25%)
Dizziness 1   (6.25%)
Numbness/Paresthesia, Dizziness, Collapse 1  (6.25%)
Painful (stopped in the first region or in the second region) 2 (12.5%)
Complications from the intervention
1. Panniculitis – 1  needed treatment – antibiotic and local 
treatment
2. Deep infection                   - 0
3. Bowel perforation             - 0
4. Pulmonary embolism       - 0
5. Deep venous thrombosis   - 0
6. Fat embolism                     - 0
7. Death                                 - 0
Table  3.    Reaction upon intervention
Table  4.    Complications from the intervention
Discussion
To allow accurate safety of TLA during 
liposuction as exclusively used local an-
esthesia, prudent choice of patientswas 
done: healthy women, no medication 
and medical history, procedures were 
performed during periovulatory phase. 
It was foundthat mean bleeding time 
at follicular phase was significantly 
shorter (P<0.05) as compared to that 
at menstrual and luteal phases. Also, 
mean clotting time at follicular phase 
was comparatively less shorter than 
that at menstrual and luteal phases, 
but the difference was not significant 
(P>0.05)8,9. Meticulously were followed 
guidelines for preparing and admin-
istrating of the TLA, whereas the safe 
maximum dosage of tumescent lido-
caine (with epinephrine)is at concen-
trations between 45 mg/kg to 50 mg/
kg10. Jeffry Klein in his study with 41 tu-
mescent infiltration procedures among 
14 volunteer subjects, with tumescent 
lidocaine dosages ranging from 19.2 to 
52 mg/kg, divided procedures in two 
groups: with and without liposuction. 
He measured serum lidocaine concen-
trations over the 24-hour study peri-
od. It was concluded that preliminary 
estimates for maximum safe dosages 
of tumescent lidocaine were 28 mg/kg 
without liposuction and 45 mg/kg with 
liposuction11. The recommendation by 
the American Academy of Dermatology 
Association, 2018, is usage of a maxi-
mum dose of 55 mg/kg of lidocaine with 
epinephrine that has been demonstrat-
ed to be safe and can be used for tumes-
cent local anesthesia for liposuction in 
patients weighing 43.6 – 81.8 kg. In our 
study the average lidocaine dosage was 
25.96 mg/kg (18.88- 50.6 mg/kg), which 
is lower than the recommended safe 
dosage. This might be a result of per-
forming the procedure as an in-office. 
In the study of Klein11 liposuction was 
done after allowing at least 1 hour of 
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detumescence for gradual dispersion of 
subcutaneous tumescent fluid. Howev-
er, in our study liposuction was started 
5-8 minutes after the end of infiltration 
to allow a proper anesthesia of the area 
and proper vasoconstriction of the sub-
cutaneous tissue. In such a case the 
resorption of lidocaine and adrenaline 
in the blood is decreased and the safety 
of the procedure is higher. In our case 
effects of lidocaine were good; only in 
12.5% (2 patients) the procedure was 
stopped because of onset of a severe 
pain, one in the first region and one in 
the second region; 68.8% (11 patients) 
were satisfied and happy, and the ef-
fects of the adrenaline were satisfacto-
ry because supernatant fat from the as-
piration was with mean 75.8% (1353 ml). 
However, the procedure is also slow, 
taking 3–4 hours to perform and also, 
the amount of fat that can be extracted 
is usually limited to about 4–5 litres12. 
In our study the maximum amount of 
fat aspirated was 3500 ml with mean 
aspirate of 1787 ml, because the body 
weight of the patients was mean 76.9 
kg (69 kg-92 kg) and the amount of in-
filtrated solution depends from calcu-
lated safe dose of lidocaine on a body 
weight.
Roland Boeni13 analyzed the safety of 
tumescent liposuction performed un-
der local anesthesia in a larger group 
of patients, between 2003 and 2010. A 
total of 4,380 consecutive patients un-
derwent tumescent liposuction by the 
same surgeon. There were no serious 
complications requiring hospitaliza-
tion. It was concluded that tumescent 
liposuction under local anesthesia is a 
safe method performed by an experi-
enced surgeon and providing the guide-
lines of care for liposuction are strictly 
followed.
There is a study that proved safety of li-
posuction using exclusively tumescent 
local anesthesia in 3,240 consecutive 
cases14 involving treatment of 7,511 body 
area; the male to female ratio was 1:9, 
and the average age was 43 (range 16–
81), much older than in this study – 32 
years (range 24-46). The average amount 
of tumescent solution infiltrated was 
3,689 mL (range 10–14,300 mL), and the 
average lidocaine dosage was 33.6 mg/
kg of body weight (ranging from 0.5 to 
86 mg/kg). For tumescent solution was 
used buffered normosaline with adren-
aline and with lidocaine from 400 mg-
1000 mg in 1000 ml normosaline;  con-
centration of lidocaine was 0.04%-0.1% 
of lidocaine. In this study, Louis Habbe-
ma reported that no deaths occurred, 
there were no complications that need-
ed hospitalization, and no legal claims 
were initiated, although there were a 
number of complications that needed 
further action (generalized edema, al-
lergic reaction to penicillin, small skin 
necrosis, hematoma, panniculitis. In 
our study toxicity from tumescent was 
observed in 6.3% (1 patient). She was 24 
years old, BMI 30 (79 kg/161sm), infil-
trated with 5000 ml tumescent solution 
0,075% lidocaine, 4000 mg lidocaine, 
or 50.6 mg/kg, aspirated 3500 ml from 
two body areas – abdomen and arms; 
the entire procedure lasted 3 and a half 
hour and no signs of intoxication were 
observed. Half an hour after the com-
pletion of the procedure, the patient 
presented with mild signs of lidocaine 
toxicity- she felt paresthesia on her left 
arm, dizziness and she collapsedtwice.. 
Blood pressure and pulse were in nor-
mal range. There was no need of medi-
cal treatment and hospitalization; just 
rest and fluid intake, hydration were 
advised. After 24 hours following the 
procedure all signs disappeared and 
she felt very satisfied. In 6.3% (1 patient) 
there was one complication from the 
procedure and that was panniculitis on 
the upper arm, an inflammation of sub-
cutaneous adipose tissue, treated suc-
cessfully in a few days with antibiotics 
and local anti-inflammatory ointments. 
There were no complications that 
needed hospitalization, and no deaths 
occurred. The results obtained in our 
study might be explained by the use of 
smaller amount of tumescent solution - 
average amount of tumescent solution 
infiltrated was 2506 mL (range 1600- 
maximum was 5000 mL), and the aver-
age lidocaine dosage was 25.96 mg/kg 
of body weight (ranging from 18.88-50.6 
mg/kg) with constant concentration of 
lidocaine 800 mg in 1000 ml normosa-
line - 0.075% concentration of lidocaine 
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in the solution.
Tumescent anesthesia used exclusively 
for regional anesthesia, without iv se-
dation or general anesthesia increas-
es the safety of TLA. General anesthe-
sia with halothane plus nitrous oxide 
causes an elevation in lidocaine plasma 
concentrations. Systemic anesthesia 
can have two dangerous effects in the 
setting of tumescent liposuction, as fol-
lows: general anesthesia can lower the 
maximum safe dose of lidocaine, such a 
potentially dangerous drug interaction 
is likely to result from competition and 
inhibition of hepatic CYP3A4, as well as 
decreased hepatic blood flow. General 
anesthesia can suppress lidocaine-in-
duced seizures, which might otherwise 
act as premonitory signs of impending 
cardiac toxicity, including fatal cardio-
vascular collapse15.
Conclusion
This study analyzed a series of 16 sub-
jects who underwent liposuction with 
TLA as sole local regional anesthesia 
technique leading to following conclu-
sion: prudent choose of patients and 
dosage of lidocaine makes TLA a safe 
technique; there were no evidence of 
lidocaine or epinephrine toxicity that 
needed medical treatment or hospital-
ization. This technique is very easy to 
be performed; provides good anesthe-
sia to the region and is a safe procedure 
for in-office surgery. Tumescent anes-
thesia is used exclusively for regional 
anesthesia, without iv sedation.
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